Hormone replacement therapy and venous thromboembolism

Gynécologie, obstétrique & fertilité
Nathalie TrillotB Jude

Abstract

Venous thromboemboembolism is a multigenic and a multifactorial disease. Several genetic risk factors have been identified: antithrombin, protein C and protein S deficiencies, and molecular defects in factor V gene (factor V Leiden) or factor II gene (G 20210A transition). Retrospective and prospective studies have demonstrated that hormone replacement therapy (HRT) in women is associated with a 2-3-fold increase of venous thromboembolism events. To minimize this risk, it seems desirable to carefully evaluate the individual clinical risk factors. Prescribing HRT should clearly be avoided in women with previous thromboembolic events. In case of familial thrombophilia, HRT should probably be prescribed with caution. Recent data suggest that transdermal HRT would induce a lower increase in thrombotic risk, but additional studies are needed to determine whether they can be safely used in women at risk. In each case, the net balance of risk and benefit of HRT use must consider the potential beneficial health effects, the most evident being the relief of climacteric symptoms.

References

Mar 12, 2002·British Journal of Haematology·F R RosendaalG D O Lowe
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Heidi D NelsonJanet D Allan
Aug 21, 2003·Lancet·Pierre-Yves ScarabinUNKNOWN EStrogen and THromboEmbolism Risk Study Group

❮ Previous
Next ❯

Citations

Jan 14, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Honghui ZhaoXiaofeng Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Annales de cardiologie et d'angéiologie
J Emmerich, M Aiach
Arteriosclerosis, Thrombosis, and Vascular Biology
Carla Y VossenF R Rosendaal
Hematology/oncology Clinics of North America
L HeilmannG F von Tempelhoff
© 2021 Meta ULC. All rights reserved